Trial
NCT00792740
Effect of ITF2357 on Mucosal Healing in Patients With Moderate-to-severe Active Crohn's Disease
Phase ITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
Italfarmaco
Collaborators
—
Condition
Crohn's Disease
Intervention
ITF2357
Why stopped
As no safety warnings were detected, Interim analysis from the first 40 patients recommends to stop the trial for futility
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-07-19